Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib
Yonesaka, K, Hirotani, K, Kawakami, H, Takeda, M, Kaneda, H, Sakai, K, Okamoto, I, Nishio, K, Jänne, P A, Nakagawa, KLanguage:
english
Journal:
Oncogene
DOI:
10.1038/onc.2015.142
Date:
May, 2015
File:
PDF, 1.78 MB
english, 2015
File converter
More search results
More benefits 
